ID   WMUi013-A
AC   CVCL_A4EM
SY   iPS-Cas9; WMUi006-A
DR   hPSCreg; WMUi013-A
DR   Wikidata; Q105511759
RX   PubMed=33207306;
CC   From: Wenzhou Medical University; Wenzhou; China.
CC   Population: Chinese; Han.
CC   Characteristics: Using CRISPR/Cas9 a HA/L-TetOn-Cas9-CMV-PuroR-2A-HA/R construct was introduced in the AAVS1 safe harbor locus (PubMed=33207306).
CC   Transfected with: UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Transfected with: UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Transfected with: UniProtKB; P13249; S.alboniger pac (PuroR).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
RX   PubMed=33207306; DOI=10.1016/j.scr.2020.102064;
RA   Ding Y.-J., Wang L., Ji W.-P., Chen Z.-G., Wang D.-X., Chen C.-D.,
RA   Tong H.-F., Han Z., Niu C., Chu M.-P., Huang J.-Y., Guo X.-L.;
RT   "Generation of a human induced pluripotent stem cell line with Cas9
RT   driven by Tet-on operator via AAVS1 safe harbor gene-editing.";
RL   Stem Cell Res. 49:102064-102064(2020).
//